All Stories

  1. Deep Analysis of Desmoglein-3–Reactive CD4+ T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature
  2. Booster Injection with Birch Pollen Extract Activates B‐Cellular Memory Responses in Patients Having Completed Allergen Immunotherapy
  3. Desmosomal Hyper-Adhesion Affects Direct Inhibition of Desmoglein Interactions in Pemphigus
  4. Follicular T-helper cells in bullous pemphigoid: how polarization affects the pathophysiology of B-cell-mediated autoimmune diseases
  5. A regulatory network of type I interferon
  6. Extracellular vesicles: Messengers of allergic immune responses and novel therapeutic strategy
  7. EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance
  8. We are memory: B‐cell responses in allergy and tolerance
  9. Isolation of Lymphocytes from Human Skin and Murine Tissues: A Rapid and Epitope-Preserving Approach
  10. Skin Tests versus Serology: Specific IgE May Suffice for Diagnosis of Vespid Venom Allergy and Follow-Up of Allergen Immunotherapy
  11. A consensus protocol for the Basophil Activation Test for multicenter collaboration and External Quality Assurance
  12. Structural and functional analyses of antibodies specific for modified core N‐glycans suggest a role in TH2 responses
  13. Nanobody‐based human antibody formats act as IgE surrogate in hymenoptera venom allergy
  14. Omalizumab response correlates with reduced IFN‐γ‐, IL‐10‐ and IL‐31‐secreting cells in chronic spontaneous urticaria
  15. Structure of intact IgE and the mechanism of ligelizumab revealed by electron microscopy
  16. The honey bee venom allergen Api m 10 displays one major IgE epitope, Api m 10160‐174
  17. Allergen immunotherapy with the hypoallergenic B‐cell epitope‐based vaccine BM32 modifies IL‐10‐ and IL‐5‐secreting T cells
  18. Birch pollen allergen‐specific immunotherapy with glutaraldehyde‐modified allergoid induces IL‐10 secretion and protective antibody responses
  19. Influenza-derived peptides cross-react with allergens and provide asthma protection
  20. Evaluation of a modified skin prick test for diagnosis of Hymenoptera venom allergy
  21. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction
  22. Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions
  23. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model
  24. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects
  25. Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria
  26. Diagnostik von Arzneimittelüberempfindlichkeiten
  27. IgE and allergen‐specific immunotherapy‐induced IgG4 recognize similar epitopes of Bet v 1, the major allergen of birch pollen
  28. Research Techniques Made Simple: Monitoring of T-Cell Subsets using the ELISPOT Assay
  29. Monitoring the epitope recognition profiles of IgE, IgG 1 , and IgG 4 during birch pollen immunotherapy
  30. The diversity of Bet v 1–specific IgG4 antibodies remains mostly constant during the course of birch pollen immunotherapy
  31. Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy
  32. CD3-Positive B Cells: A Storage-Dependent Phenomenon
  33. Zelluläre In-vitro-Diagnostik von Arzneimittelreaktionen
  34. Cellular in vitro diagnosis of adverse drug reactions
  35. Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies
  36. Birch Pollen Immunotherapy Leads to Differential Induction of Regulatory T Cells and Delayed Helper T Cell Immune Deviation